Endcap
Sign inJoin
GLP-1ActiveCloses in 12 months on May 1, 2027
Share / Embed

Lilly vs Novo: bigger GLP-1 share gain in 2026: Eli Lilly (tirzepatide)

40%YES chance
Yes
40%
No
60%

Now 40.2%

Resolution

Resolves to the manufacturer with the larger US GLP-1 prescription share gain across calendar 2026.

Source: https://www.iqvia.com/

Resolves by May 8, 2027.

Recent trades

  • YES@tatumchen
    146.5 sh@ 40%54 SP
  • NO@kaidiaz
    96.5 sh@ 34%62 SP
  • NO@audenpark
    44.2 sh@ 38%27 SP
  • NO@skylerpowell
    141.1 sh@ 40%80 SP
  • YES@taylorvargas
    75.7 sh@ 47%34 SP
  • NO@rowanmonroe
    30.2 sh@ 43%17 SP
  • NO@rowanmonroe
    43.1 sh@ 48%22 SP
  • YES@haydenlopez
    67.6 sh@ 45%29 SP
  • NO@lanechen
    93.8 sh@ 41%53 SP
  • NO@parkersantos
    140 sh@ 46%71 SP
  • YES@marlowerivera
    126.9 sh@ 53%63 SP
  • NO@sashahayes
    45.8 sh@ 46%24 SP
  • NO@wrenvargas
    77 sh@ 49%38 SP
  • NO@jordanvargas
    173.8 sh@ 53%75 SP
  • YES@rowandiaz
    138.6 sh@ 61%80 SP
  • YES@alexkhan
    70.3 sh@ 54%37 SP
  • YES@morgansantos
    139.3 sh@ 51%66 SP
  • NO@morgansantos
    79.4 sh@ 44%43 SP

Top holders

YES holders

No holders yet.

NO holders

No holders yet.

News

Refreshed every 6 hours

No news yet. Endcap's news crawler refreshes every 6 hours.

Discussion

  • @juneyoonJune Yoonlast month

    loaded up, the data is there.